Financials DexCom, Inc.

Stocks

DXCM

US2521311074

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 16:00:01 2026-06-23 EDT			5-day change	1st Jan Change
68.92 ^USD	-0.22%		-5.80%	+3.84%

07:20am	Deutsche Bank Initiates Coverage on DexCom With Buy Rating, $86 Price Target	MT
06-16	AI Can Play 'Significant' Role in Tech for Managing Diabetes, Says David Roman	MT

Projected Income Statement: DexCom, Inc.

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Net sales ¹	2,448	2,910	3,622	4,033	4,662	5,225	5,830	6,523
Change	-	18.84%	24.49%	11.34%	15.6%	12.07%	11.57%	11.9%
EBITDA ¹	472.7	751.6	1,014	1,105	1,349	1,639	1,915	2,228
Change	-	59%	34.98%	8.92%	22.05%	21.55%	16.81%	16.37%
EBIT ¹	370.7	485.1	718.6	757.1	969.3	1,212	1,438	1,723
Change	-	30.86%	48.13%	5.36%	28.03%	25.08%	18.62%	19.81%
Interest Paid ¹	-90.4	-0.4	-	109	-18.3	-12.9	-16.85	-17.5
Earnings before Tax (EBT) ¹	173.9	390.8	710.4	709	1,088	1,258	1,478	1,728
Change	-	124.73%	81.78%	-0.2%	53.51%	15.62%	17.47%	16.89%
Net income ¹	154.7	341.2	541.5	576.2	836.3	964.3	1,157	1,378
Change	-	120.56%	58.7%	6.41%	45.14%	15.31%	19.97%	19.07%
Announcement Date	2/10/22	2/9/23	2/8/24	2/13/25	2/12/26	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 Q3	2027 Q4	2028 Q1
Net sales ¹	595.1	650.2	698.2	628.8	696.2	769.6	815.2	741.5	871.3	975	1,034	921	1,004	994.2	1,114	1,036	1,157	1,209	1,260	1,192	1,290	1,335	1,405	1,324	1,435	1,484	1,553	1,480
Change	-	9.26%	7.38%	-9.94%	10.72%	10.54%	5.93%	-9.04%	17.51%	11.9%	6.1%	-10.97%	9.04%	-1.01%	12%	-6.96%	11.69%	4.51%	4.16%	-5.37%	8.26%	3.49%	5.2%	-5.77%	8.45%	3.4%	4.61%	-4.67%
EBITDA ¹	125	149.3	131.1	112.4	175.5	226.6	237.1	145.9	232.6	314.5	321.5	220.9	283.9	300.1	300.1	230.4	327.6	368.4	422.2	364.5	390.3	425.1	459.7	410	454	491.8	535.4	503.2
Change	-	19.44%	-12.19%	-14.26%	56.14%	29.12%	4.63%	-38.46%	59.42%	35.21%	2.23%	-31.29%	28.52%	5.71%	0%	-23.23%	42.19%	12.45%	14.6%	-13.67%	7.07%	8.94%	8.14%	-10.81%	10.72%	8.33%	8.85%	-6.02%
EBIT ¹	101.5	123.8	99	50.3	101.9	160.8	172.1	78.6	158.4	238.9	242.7	140.2	195.4	212	209.5	143.1	221.8	272.9	331.5	264.4	284.1	315.1	351.1	293.1	335.3	373.5	418.4	375.7
Change	-	21.97%	-20.03%	-49.19%	102.58%	57.8%	7.03%	-54.33%	101.53%	50.82%	1.59%	-42.23%	39.37%	8.5%	-1.18%	-31.69%	55%	23.04%	21.47%	-20.24%	7.46%	10.9%	11.41%	-16.49%	14.37%	11.4%	12.02%	-10.21%
Charge d'intérêts ¹	-24.3	-23.4	-25.2	-5.2	-1.7	-1.3	7.8	17.3	31.2	33.9	-	31.4	-29.8	25.4	22.4	20.6	-4.7	-4.7	-4.2	-3.1	-3.3	-3.3	-3.3	-3.8	-3.8	-3.8	-3.8	-
Earnings before Tax (EBT) ¹	76.7	90.7	-14.7	36.1	75.3	146.2	133.2	64.5	159.3	240.4	246.2	132.5	187.8	177.4	211.3	154.3	241.1	352.3	340.7	269.5	303.6	328.8	361.9	310.5	352.4	385.9	423.8	388.8
Change	-	18.25%	-116.21%	345.58%	108.59%	94.16%	-8.89%	-51.58%	146.98%	50.91%	2.41%	-46.18%	41.74%	-5.54%	19.11%	-26.98%	56.25%	46.12%	-3.29%	-20.9%	12.66%	8.31%	10.06%	-14.22%	13.51%	9.51%	9.82%	-8.27%
Net income ¹	62.9	70.9	-19.4	97.3	50.9	101.2	91.8	48.6	115.9	120.7	256.3	146.4	143.5	134.6	151.7	105.4	179.8	283.8	267.3	199.5	231.7	257.5	281.6	238.5	270	295.7	324.6	301.8
Change	-	12.72%	-127.36%	601.55%	-47.69%	98.82%	-9.29%	-47.06%	138.48%	4.14%	112.34%	-42.88%	-1.98%	-6.2%	12.7%	-30.52%	70.59%	57.84%	-5.81%	-25.36%	16.12%	11.18%	9.34%	-15.32%	13.22%	9.51%	9.79%	-7.02%
Announcement Date	7/29/21	10/28/21	2/10/22	4/28/22	7/28/22	10/27/22	2/9/23	4/27/23	7/27/23	10/26/23	2/8/24	4/25/24	7/25/24	10/24/24	2/13/25	5/1/25	7/30/25	10/30/25	2/12/26	4/30/26	-	-	-	-	-	-	-	-

¹USD in Million

Estimates

Forecast Balance Sheet: DexCom, Inc.

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Net Debt ¹	650	1,328	1,868	696	323	-405	-1,211	-2,221
Change	-	104.31%	40.66%	-62.74%	-53.59%	-225.31%	-199.01%	-83.4%
Announcement Date	2/10/22	2/9/23	2/8/24	2/13/25	2/12/26	-	-	-

¹USD in Million

Estimates

Cash Flow Forecast: DexCom, Inc.

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
CAPEX ¹	389.2	364.8	236.6	358.8	363.5	372.6	387	410.1
Change	-	-6.27%	-35.14%	51.65%	1.31%	2.5%	3.86%	5.98%
Free Cash Flow (FCF) ¹	53.3	305	511.9	630.7	1,077	993.5	1,243	1,517
Change	-	472.23%	67.84%	23.21%	70.79%	-7.77%	25.09%	22.03%
Announcement Date	2/10/22	2/9/23	2/8/24	2/13/25	2/12/26	-	-	-

¹USD in Million

Estimates

Forecast Financial Ratios: DexCom, Inc.

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Profitability
EBITDA Margin (%)	19.31%	25.83%	28.01%	27.4%	28.93%	31.37%	32.85%	34.16%
EBIT Margin (%)	15.14%	16.67%	19.84%	18.77%	20.79%	23.2%	24.67%	26.41%
EBT Margin (%)	7.1%	13.43%	19.61%	17.58%	23.35%	24.09%	25.36%	26.49%
Net margin (%)	6.32%	11.73%	14.95%	14.29%	17.94%	18.46%	19.85%	21.12%
FCF margin (%)	2.18%	10.48%	14.13%	15.64%	23.11%	19.01%	21.32%	23.25%
FCF / Net Income (%)	34.45%	89.39%	94.53%	109.46%	128.81%	103.02%	107.41%	110.09%
Profitability
ROA	5.83%	6.78%	9.29%	9.2%	13.04%	14.34%	15.47%	15.81%
ROE	13.08%	16.77%	25.78%	27.63%	34.16%	33.3%	34.17%	32.03%
Financial Health
Leverage (Debt/EBITDA)	1.38x	1.77x	1.84x	0.63x	0.24x	-	-	-
Debt / Free cash flow	12.2x	4.35x	3.65x	1.1x	0.3x	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	15.9%	12.54%	6.53%	8.9%	7.8%	7.13%	6.64%	6.29%
CAPEX / EBITDA (%)	82.34%	48.54%	23.32%	32.47%	26.95%	22.73%	20.21%	18.41%
CAPEX / FCF (%)	730.21%	119.61%	46.22%	56.89%	33.74%	37.5%	31.14%	27.04%
Items per share
Cash flow per share ¹	1.105	1.566	1.759	2.398	3.553	3.963	4.3	4.996
Change	-	41.7%	12.33%	36.3%	48.19%	11.55%	8.49%	16.2%
Dividend per Share ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Book Value Per Share ¹	5.803	5.518	5.367	5.164	7.136	7.084	8.249	10.83
Change	-	-4.9%	-2.74%	-3.8%	38.2%	-0.73%	16.45%	31.23%
EPS ¹	0.3875	0.82	1.3	1.42	2.09	2.461	2.938	3.545
Change	-	111.61%	58.54%	9.23%	47.18%	17.76%	19.39%	20.65%
Nbr of stocks (in thousands)	387,688	386,258	386,374	390,595	390,016	385,873	385,873	385,873
Announcement Date	2/10/22	2/9/23	2/8/24	2/13/25	2/12/26	-	-	-